Latest It Compliance News

Alkane Resources reports a total of 1.97 million ounces of gold in Mineral Resources at its Swedish Björkdal operations, with underground mining ongoing and open pit mining paused until 2027. Exploration highlights suggest promising extensions near existing infrastructure.

Alkane Resources reports a robust 9.8 million ounce gold resource base in New South Wales as of June 2025, with ongoing underground mining at Tomingley and development progress at Boda-Kaiser.

Alkane Resources has released its FY25 Mineral Resources and Ore Reserves update, highlighting a robust asset base across Australia and Sweden and reinforcing its growth trajectory with ongoing capital investments.

Peppermint Innovation Limited (PIL) has addressed recent unusual trading activity, attributing it to growing market recognition of its recent fintech milestones rather than undisclosed information.

The ASX has released its latest list of entities suspended from trading for over three months, highlighting looming deadlines for report submissions and potential removal from the official list.

Litchfield Minerals has addressed ASX concerns over recent share price spikes, confirming active drilling at its Oonagalabi project and requesting a trading halt pending assay results.

Australia United Mining has responded to ASX inquiries following a sudden surge in its share price and trading volume, confirming no undisclosed information exists and affirming compliance with continuous disclosure rules.

Netlinkz Limited has attributed the late filing of a key director disclosure to an administrative error, while affirming its existing compliance frameworks remain robust.

ActivEX Limited has completed a significant $800,000 share placement to True Creation Limited, aiming to strengthen its financial footing and advance exploration projects.

Vectus Biosystems has temporarily paused trading of its securities pending a forthcoming announcement, signaling potential material news for investors.

QBE Insurance Group has announced the redemption of its USD 300 million 6.10% fixed rate subordinated notes due 2045, marking a notable step in its capital management strategy with regulatory approval secured.

Bod Science reports a $576k cash outflow in Q1 FY2026 amid ongoing administration and delays in Biortica audit completion. The company plans a shareholder vote in November to approve its acquisition of Biortica and exit from administration.